A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D3 Reduces T-Bet Gene Expression, Serum Interferon Gamma, and Clinical Scores but Promotes PPARγ Gene Expression in Experimental Autoimmune Encephalomyelitis-Reference-Cited by-同舟云学术

A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D3 Reduces T-Bet Gene Expression, Serum Interferon Gamma, and Clinical Scores but Promotes PPARγ Gene Expression in Experimental Autoimmune Encephalomyelitis

Published:2016-09-19 Issue:4 Volume:60 Page:498-508
ISSN:0895-8696
Container-title:Journal of Molecular Neuroscience
language:en
Short-container-title:J Mol Neurosci

Author:

Shiri-Shahsavar Mohammad Reza,Mirshafiee Abbas,Parastouei Karim,Ebrahimi-Kalan Abbas,Yekaninejad Saeed,Soleymani Farid,Chahardoli Reza,Mazaheri Nezhad Fard Ramin,Saboor-Yaraghi Ali Akbar

Funder

International Campus, Tehran University of Medical Sciences, Tehran, Iran.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12031-016-0834-4.pdf

Reference110 articles.

1. Adorini L (2004) Immunotherapeutic approaches in multiple sclerosis. J Neurol Sci 223(1):13–24

2. Adorini L (2005) Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol 233:115–124

3. Adorini L, Penna G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4(8):404–412